Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency

Human Brain Mapping

Volumn 33, Issue 1, 2012, Pages 143-153

  Prata, Diana P ^a   Papagni, Sergio A ^a,c   Mechelli, Andrea ^a   Fu, Cynthia H Y ^a   Kambeitz, Joseph ^a,d   Picchioni, Marco ^a,b   Kane, Fergus ^a   Kalidindi, Sridevi ^a   Mcdonald, Colm ^b   Kravariti, Eugenia ^a   Toulopoulou, Timothea ^a   Bramon, Elvira ^a   Walshe, Muriel ^a   Murray, Robin ^a   Collier, David A ^a   Mcguire, Philip K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY OF FOGGIA   (Italy)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

DAOA G72; FMRI; Glutamate; Psychosis; Schizophrenia; Verbal fluency

Indexed keywords

DEXTRO AMINO ACID OXIDASE; DEXTRO AMINO ACID OXIDASE ACTIVATOR; DEXTRO SERINE; GENE PRODUCT; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN G72; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; DENDRITE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; G72 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOSIS; REGULATORY MECHANISM; SCHIZOPHRENIA; VERBAL BEHAVIOR;

ADULT; BRAIN; BRAIN MAPPING; CARRIER PROTEINS; FEMALE; GENOTYPE; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE NET; NEUROIMAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; VERBAL BEHAVIOR;

EID: 83455199102     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21198     Document Type: Article

References (101)

1. Addington AM, Gornick M, Sporn AL, Gogtay N, Greenstein D, Lenane M, Gochman P, Baker N, Balkissoon R, Vakkalanka RK, Weinberger DR, Straub RE, Rapoport JL ( 2004): Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 55: 976-980.
2. Allen HA, Liddle PF, Frith CD ( 1993): Negative features, retrieval processes and verbal fluency in schizophrenia. Br J Psychiatry 163: 769-775.
3. Ammons RB, Ammons CH ( 1962): Quick Test. Missoula, MT: Psychological Test Specialists.
4. Artiges E, Martinot JL, Verdys M, ttar-Levy D, Mazoyer B, Tzourio N, Giraud MJ, Paillere-Martinot ML ( 2000): Altered hemispheric functional dominance during word generation in negative schizophrenia. Schizophr Bull 26: 709-721.
5. Baldo JV, Schwartz S, Wilkins D, Dronkers NF ( 2006): Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc 12: 896-900.
6. Barch DM, Csernansky JG ( 2007): Abnormal parietal cortex activation during working memory in schizophrenia: Verbal phonological coding disturbances versus domain-general executive dysfunction. Am J Psychiatry 164: 1090-1098.
7. Bass NJ, Datta SR, McQuillin A, Puri V, Choudhury K, Thirumalai S, Lawrence J, Quested D, Pimm J, Curtis D, Gurling HM ( 2009): Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. Behav Brain Funct 5: 28.
8. Benzel I, Kew J, Viknaraja R, Kelly F, de Belleroche J, Hirsch S, Sanderson T, Maycox P ( 2008): Investigation of G72 (DAOA) expression in the human brain. BMC Psychiatry 8: 94.
9. Boks MPM, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ, Kahn RS ( 2007): Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol 17: 567-572.
10. Broome M, Matthiasson P, Fusar-Poli P, Woolley J, Johns L, Tabraham P, Bramon E, Valmaggia L, Williams S, Brammer M, Chitnis X, McGuire ( 2009): Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry 194: 25-33.
11. Buchanan RW, Francis A, Arango C, Miller K, Lefkowitz DM, McMahon RP, Barta PE, Pearlson GD ( 2004). Morphometric Assessment of the Heteromodal Association Cortex in Schizophrenia. Am J Psychiatry 161: 322-331.
12. Celsis P, Boulanouar K, Doyon B, Ranjeva JP, Berry I, Nespoulous JL, Chollet F ( 1999): Differential fMRI responses in the left posterior superior temporal gyrus and left supramarginal gyrus to habituation and change detection in syllables and tones. Neuroimage 9: 135-144.
13. Chang YL, Jacobson M, Fennema-Notestine C, Hagler JrDJ, Jennings RG, Dale AM, McEvoy L ( 2009): Executive function, prefrontal and posterior cingulate cortices influence verbal memory performance in amnestic mild cognitive impairment. Neuroimage 47( Suppl 1): S112.
14. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La RP, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, urich-Costa J, Cherif D, Gimalac A, Van DC, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D ( 2002): Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99: 13675-13680.
15. Clower DM, West RA, Lynch JC, Strick PL ( 2001): The inferior parietal lobule is the target of output from the superior colliculus, hippocampus, and cerebellum. J Neurosci 21: 6283-6291.
16. Corvin A, McGhee KA, Murphy K, Donohoe G, Nangle JM, Schwaiger S, Kenny N, Clarke S, Meagher D, Quinn J, Scully P, Baldwin P, Browne D, Walsh C, Waddington JL, Morris DW, Gill M ( 2007): Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet 144: 949-953.
17. Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG, Sharma TS, Murray RM, McGuire PK ( 1998): Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 155: 1056-1063.
18. Düzel E, Cabeza R, Picton TW, Yonelinas AP, Scheich H, Heinze HJ, Tulving E ( 1999): Task-related and item-related brain processes of memory retrieval. Proc Natl Acad Sci USA 96: 1794-1799.
19. Detera-Wadleigh SD, McMahon FJ ( 2006): G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis. Biol Psychiatry 60: 106-114.
20. Fink GR, Markowitsch HJ, Reinkemeier M, Bruckbauer T, Kessler J, Heiss WD ( 1996): Cerebral representation of one's own past: Neural networks involved in autobiographical memory. J Neurosci 16: 4275-4282.
21. Fletcher PC, Frith CD, Grasby PM, Friston KJ, Dolan RJ ( 1996): Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci 16: 7055-7062.
22. Franck N, O'Leary DS, Flaum M, Hichwa RD, Andreasen NC ( 2002): Cerebral blood flow changes associated with schneiderian first-rank symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci 14: 277-282.
23. Frederikse M, Lu A, Aylward E, Barta P, Sharma T, Pearlson G ( 2000): Sex differences in inferior parietal lobule volume in schizophrenia. Am J Psychiatry 157: 422-427.
24. Friedman L, Kenny JT, Wise AL, Wu D, Stuve TA, Miller DA, Jesberger JA, Lewin JS ( 1998): Brain activation during silent word generation evaluated with functional MRI. Brain Lang 64: 231-256.
25. Friston KJ ( 2003): Introduction: Experimental design and statistical parametric mapping. In: Frackowiak RS, Friston KJ, Frith C, Dolan R, Price CJ, Zeki S, Ashburner J, Penny WD, editors. Human Brain Function. Academic Press: San Diego, California, USA, pp 599-634.
26. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ ( 1997): Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 6: 218-229.
27. Frith CD, Friston KJ, Herold S, Silbersweig D, Fletcher P, Cahill C, Dolan RJ, Frackowiak RS, Liddle PF ( 1995): Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry 167: 343-349.
28. Frith CD, Leary J, Cahill C, Johnstone EC ( 1991): Performance on psychological tests. Demographic and clinical correlates of the results of these tests. Br J Psychiatry Suppl ( 13): 26.
29. Fu CH, Morgan K, Suckling J, Williams SC, Andrew C, Vythelingum GN, McGuire PK ( 2002): A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: Greater anterior cingulate activation with increased task demand. Neuroimage 17: 871-879.
30. Fu CH, Suckling J, Williams SC, Andrew CM, Vythelingum GN, McGuire PK ( 2005): Effects of psychotic state and task demand on prefrontal function in schizophrenia: An fMRI study of overt verbal fluency. Am J Psychiatry 162: 485-494.
31. Geyer S, Schleicher A, Zilles K ( 1997): The somatosensory cortex of human: Cytoarchitecture and regional distributions of receptor-binding sites. Neuroimage 6: 27-45.
32. Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, Coppola R, Egan MF, Weinberger DR ( 2006): The G72//G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 31: 2022-2032.
33. Gur RE, Keshavan MS, Lawrie SM ( 2007): Deconstructing psychosis with human brain imaging. Schizophr Bull 33: 921-931.
34. Hall D, Gogos JA, Karayiorgou M ( 2004): The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 3: 240-248.
35. Hall J, Whalley HC, Moorhead TW, Baig BJ, McIntosh AM, Job DE, Owens DG, Lawrie SM, Johnstone EC ( 2008): Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia. Biol Psychiatry 64: 428-433.
36. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel BV Jr, Lohr J, Wu J, Haier RJ, Bunney WE Jr ( 1997): Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 154: 682-684.
37. Heim S, Eickhoff SB, Amunts K ( 2008): Specialisation in Broca's region for semantic, phonological, and syntactic fluency? Neuroimage 40: 1362-1368.
38. Heresco-Levy U ( 2005): Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia. Expert Opin Emerg Drugs 10: 827-844.
39. Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, Catinari S, Ermilov M ( 2005): D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 57: 577-585.
40. Hirshorn EA, Thompson-Schill SL ( 2006): Role of the left inferior frontal gyrus in covert word retrieval: Neural correlates of switching during verbal fluency. Neuropsychologia 44: 2547-2557.
41. Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA ( 2000): Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. Am J Psychiatry 157: 1634-1645.
42. Howanitz E, Cicalese C, Harvey PD ( 2000): Verbal fluency and psychiatric symptoms in geriatric schizophrenia. Schizophr Res 42: 167-169.
43. Hulshoff Pol HE, Schnack HG, Mandl RCW, van Haren NEM, Koning H, Collins DL, Evans AC, Kahn RS ( 2001): Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 58: 1118-1125.
44. Hutchinson M, Schiffer W, Joseffer S, Liu A, Schlosser R, Dikshit S, Goldberg E, Brodie JD ( 1999): Task-specific deactivation patterns in functional magnetic resonance imaging. Magn Reson Imaging 17: 1427-1436.
45. Jansen A, Krach S, Krug A, Markov V, Eggermann T, Zerres K, Stocker T, Shah NJ, Nothen MM, Treutlein J, Rietschel M, Kircher T ( 2009): A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe. Neuroimage 45: 1002-1008.
46. Kiehl KA, Liddle PF ( 2001): An event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia. Schizophr Res 48: 159-171.
47. Korostishevsky M, Kremer I, Kaganovich M, Cholostoy A, Murad I, Muhaheed M, Bannoura I, Rietschel M, Dobrusin M, ing-Abu-Shach U, Belmaker RH, Maier W, Ebstein RP, Navon R ( 2006): Transmission disequilibrium and haplotype analyses of the G72/G30 locus: Suggestive linkage to schizophrenia in Palestinian Arabs living in the North of Israel. Am J Med Genet B Neuropsychiatr Genet 141: 91-95.
48. Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, Bernstein J, ing-Abu-Shach U, Ben-Asher E, Lancet D, Ritsner M, Navon R ( 2004): Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 56: 169-176.
49. Krause BJ, Horwitz B, Taylor JG, Schmidt D, Mottaghy FM, Herzog H, Halsband U, Muller-Gartner H ( 1999): Network analysis in episodic encoding and retrieval of word-pair associates: A PET study. Eur J Neurosci 11: 3293-3301.
50. Krug A, Markov V, Krach S, Jansen A, Zerres K, Eggermann T, Stocker T, Shah NJ, Nothen MM, Georgi A, Strohmaier J, Rietschel M, Kircher T ( 2010): Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals. Hum Brain Mapp (e-pub ahead of print).
51. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS ( 1994): Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
52. Krystal JH, DGÇÖSouza DC, Karper LP, Bennett A, Bi-Dargham A, bi-Saab D, Cassello K, Bowers J, Vegso S, Heninger GR, Charney DS, Bowers MB ( 1999): Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology 145: 193-204.
53. Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA ( 2007): Evidence implicating the candidate schizophrenia//bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 13: 685-696.
54. Lane HY, Chang YC, Liu YC, Chiu CC, Tsai GE ( 2005): Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: A randomized, double-blind, placebo-controlled study. Arch Gen Psychiatry 62: 1196-1204.
55. Leonard CM, Kuldau JM, Breier JI, Zuffante PA, Gautier ER, Heron DC, Lavery EM, Packing J, Williams SA, DeBose CA ( 1999): Cumulative effect of anatomical risk factors for schizophrenia: An MRI study. Biol Psychiatry 46: 374-382.
56. Lim HK, Juh R, Pae CU, Lee BT, Yoo SS, Ryu SH, Kwak KR, Lee C, Lee CU ( 2008): Altered verbal working memory process in patients with Alzheimer's disease. Neuropsychobiology 57: 181-187.
57. Lurito JT, Kareken DA, Lowe MJ, Chen SH, Mathews VP ( 2000): Comparison of rhyming and word generation with FMRI. Hum Brain Mapp 10: 99-106.
58. Maddock RJ, Garrett AS, Buonocore MH ( 2001): Remembering familiar people: The posterior cingulate cortex and autobiographical memory retrieval. Neuroscience 104: 667-676.
59. Maguire EA, Frith CD, Morris RGM ( 1999): The functional neuroanatomy of comprehension and memory: the importance of prior knowledge. Brain 122: 1839-1850.
60. Meda SA, Stevens MC, Folley BS, Calhoun VD, Pearlson GD ( 2009): Evidence for anomalous network connectivity during working memory encoding in schizophrenia: An ICA based analysis. PLoS ONE 4: e7911.
61. Mensebach C, Beblo T, Driessen M, Wingenfeld K, Mertens M, Rullkoetter N, Lange W, Markowitsch HJ, Ollech I, Saveedra AS, Rau H, Woermann FG ( 2009): Neural correlates of episodic and semantic memory retrieval in borderline personality disorder: An fMRI study. Psychiatry Res 171: 94-105.
62. Miller DD, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD ( 2001): Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry 49: 704-715.
63. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW ( 1999): Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20: 106-118.
64. Niznikiewicz M, Donnino R, McCarley RW, Nestor PG, Iosifescu DV, OæDonnell B, Levitt J, Shenton ME ( 2000): Abnormal angular gyrus asymmetry in schizophrenia. Am J Psychiatry 157: 428-437.
65. Northoff G, Richter A, Bermpohl F, Grimm S, Martin E, Marcar VL, Wahl C, Hell D, Boeker H ( 2005): NMDA hypofunction in the posterior cingulate as a model for schizophrenia: An exploratory ketamine administration study in fMRI. Schizophr Res 72: 235-248.
66. Olney JW, Farber NB ( 1995): Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52: 998-1007.
67. Opgen-Rhein C, Lencz T, Burdick KE, Neuhaus AH, DeRosse P, Goldberg TE, Malhotra AK ( 2008): Genetic variation in the DAOA gene complex: Impact on susceptibility for schizophrenia and on cognitive performance. Schizophr Res 103: 169-177.
68. Owen MJ, Williams NM, O'Donovan MC ( 2004): The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 9: 14-27.
69. Parwani A, Weiler M, Blaxton T, Warfel D, Hardin M, Frey K, Lahti A ( 2005): The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology 183: 265-274.
70. Passani LA, Vonsattel JP, Coyle JT ( 1997): Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease. Brain Res 772: 9-22.
71. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD ( 2007): Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized phase 2 clinical trial. Nat Med 13: 1102-1107.
72. Penny WD, Holmes AP, Friston KJ ( 2003): Random effects analysis. In: Frackowiak RS, Friston KJ, Frith C, Dolan R, Price CJ, Zeki S, Ashburner J, Penny WD, editors. Human Brain Function. Academic Press: San Diego, California, USA, pp 843-850.
73. Peters F, Collette F, Degueldre C, Sterpenich V, Majerus S, Salmon E ( 2009): The neural correlates of verbal short-term memory in Alzheimer's disease: An fMRI study. Brain 132: 1833-1846.
74. Phelps EA, Hyder F, Blamire AM, Shulman RG ( 1997): FMRI of the prefrontal cortex during overt verbal fluency. Neuroreport 8: 561-565.
75. Prata D, Breen G, Osborne S, Munro J, St CD, Collier D ( 2008): Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 147: 914-917.
76. Prata DP, Mechelli A, Fu CH, Picchioni M, Toulopoulou T, Bramon E, Walshe M, Murray RM, Collier DA, McGuire P ( 2009): Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Natl Acad Sci USA 106: 13600-13605.
77. Ries ML, Schmitz TW, Kawahara TN, Torgerson BM, Trivedi MA, Johnson SC ( 2006): Task-dependent posterior cingulate activation in mild cognitive impairment. Neuroimage 29: 485-492.
78. Sacchi S, Bernasconi M, Martineau M, Mothet JP, Ruzzene M, Pilone MS, Pollegioni L, Molla G ( 2008): pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase. J Biol Chem 283: 22244-22256.
79. Schell MJ, Molliver ME, Snyder SH ( 1995): D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92: 3948-3952.
80. Schlosser R, Hutchinson M, Joseffer S, Rusinek H, Saarimaki A, Stevenson J, Dewey SL, Brodie JD ( 1998): Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry 64: 492-498.
81. Schumacher J, bon Jamra R, Freudenberg J, Becker T, Ohlraun S, Otte ACJ, Tullius M, Kovalenko S, Van Den Bogaert A, Maier W, Rietschel M, Propping P, Nothen MM, Cichon S ( 2004): Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 9: 203-207.
82. Shinkai T ( 2007): Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia. Neuromolecular Med 9: 169-177.
83. Stone JM, Day F, Tsagaraki H, Valli I, McLean MA, Lythgoe DJ, O'Gorman RL, Barker GJ, McGuire PK ( 2009): Glutamate dysfunction in people with prodromal symptoms of psychosis: Relationship to gray matter volume. Biol Psychiatry 66: 533-539.
84. Sutherland RJ, Whishaw IQ, Kolb B ( 1988): Contributions of cingulate cortex to two forms of spatial learning and memory. J Neurosci 8: 1863-1872.
85. Tendolkar I, Weis S, Guddat O, Fernbndez G, Brockhaus-Dumke A, Specht K, Klosterkitter J, Reul J, Ruhrmann S ( 2004): Evidence for a dysfunctional retrosplenial cortex in patients with schizophrenia: A functional magnetic resonance imaging study with a semantic-perceptual contrast. Neurosci Lett 369: 4-8.
86. Vickery TJ, Jiang YV ( 2009): Inferior parietal lobule supports decision making under uncertainty in humans. Cereb Cortex 19: 916-925.
87. Villarreal DM, Do V, Haddad E, Derrick BE ( 2002): NMDA receptor antagonists sustain LTP and spatial memory: Active processes mediate LTP decay. Nat Neurosci 5: 48-52.
88. Vogt BA, Finch DM, Olson CR ( 1992): Functional heterogeneity in cingulate cortex: The anterior executive and posterior evaluative regions. Cereb Cortex 2: 435-437.
89. Wang J, Brown R, Dobkins KR, McDowell JE, Clementz BA ( 2010): Diminished parietal cortex activity associated with poor motion direction discrimination performance in schizophrenia. Cereb Cortex 20: 1749-1755.
90. Wang X, He G, Gu N, Yang J, Tang J, Chen Q, Liu X, Shen Y, Qian X, Lin W, Duan Y, Feng G, He L ( 2004): Association of G72/G30 with schizophrenia in the Chinese population. Biochem Biophys Res Commun 319: 1281-1286.
91. Wechsler D ( 1997): Wechsler Adult Intelligence Scale, 3rd ed Manual. San Antonio: Psychological Corporation.
92. Wechsler D ( 1999): Wechsler Abbreviated Scale of Intelligence. San Antonio: Psychological Corporation.
93. Wechsler D ( 1981): Manual for the Wechsler Intelligence Scale-Revised. San Antonio: The Psychological Corporation.
94. Wheeler DG, Harper CG ( 2007): Localised reductions in gyrification in the posterior cingulate: Schizophrenia and controls. Prog Neuropsychopharmacol Biol Psychiatry 31: 319-327.
95. Winterer G, Weinberger DR ( 2004): Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27: 683-690.
96. Wolosker H, Dumin E, Balan L, Foltyn VN ( 2008): D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration. FEBS J 275: 3514-3526.
97. Xiao Z, Zhang JX, Wang X, Wu R, Hu X, Weng X, Tan LH ( 2005): Differential activity in left inferior frontal gyrus for pseudowords and real words: An event-related fMRI study on auditory lexical decision. Hum.Brain Mapp 25: 212-221.
98. Yetkin FZ, Hammeke TA, Swanson SJ, Morris GL, Mueller WM, McAuliffe TL, Haughton VM ( 1995): A comparison of functional MR activation patterns during silent and audible language tasks. AJNR Am J Neuroradiol 16: 1087-1092.
99. Yurgelun-Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshaw PF ( 1996): Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 153: 200-205.
100. Zahr NM, Mayer D, Pfefferbaum A, Sullivan EV ( 2008): Low striatal glutamate levels underlie cognitive decline in the elderly: Evidence from in vivo molecular spectroscopy. Cereb Cortex 18: 2241-2250.
101. Zou F, Li C, Duan S, Zheng Y, Gu N, Feng G, Xing Y, Shi J, He L ( 2005): A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr Res 73: 257-261.